Anna Turletti

918 total citations
13 papers, 354 citations indexed

About

Anna Turletti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Anna Turletti has authored 13 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Anna Turletti's work include Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Treatment and Pharmacology (5 papers). Anna Turletti is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Treatment and Pharmacology (5 papers). Anna Turletti collaborates with scholars based in Italy, United States and Belgium. Anna Turletti's co-authors include Graziella Bellone, G Emanuelli, Elisa Artusio, D. Tibaudi, Ulrich Rodeck, Katia Mareschi, A Robecchi, Anna Carbone, Lina Matera and Claudia Giachino and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal Of Pathology.

In The Last Decade

Anna Turletti

13 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Turletti Italy 6 231 148 72 40 36 13 354
Yoshihisa Arita Japan 6 346 1.5× 237 1.6× 124 1.7× 49 1.2× 44 1.2× 7 461
Hyun-Joo Lee South Korea 7 151 0.7× 136 0.9× 73 1.0× 18 0.5× 61 1.7× 13 312
Yugang Wu China 14 286 1.2× 238 1.6× 113 1.6× 85 2.1× 71 2.0× 28 497
Stefania Laurent Italy 7 322 1.4× 284 1.9× 65 0.9× 17 0.4× 12 0.3× 10 448
Anthony Liew United States 5 54 0.2× 114 0.8× 139 1.9× 56 1.4× 21 0.6× 7 270
JK Larsen Denmark 12 102 0.4× 196 1.3× 86 1.2× 18 0.5× 12 0.3× 17 448
Alana M. Neale Australia 7 148 0.6× 266 1.8× 165 2.3× 21 0.5× 30 0.8× 8 386
Holger Hoff Germany 12 128 0.6× 330 2.2× 70 1.0× 16 0.4× 28 0.8× 16 460
Ahmed Bedeir United States 7 147 0.6× 48 0.3× 87 1.2× 46 1.1× 30 0.8× 9 300

Countries citing papers authored by Anna Turletti

Since Specialization
Citations

This map shows the geographic impact of Anna Turletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Turletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Turletti more than expected).

Fields of papers citing papers by Anna Turletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Turletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Turletti. The network helps show where Anna Turletti may publish in the future.

Co-authorship network of co-authors of Anna Turletti

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Turletti. A scholar is included among the top collaborators of Anna Turletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Turletti. Anna Turletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Conté, Pierfranco, Giancarlo Bisagni, Federico Piacentini, et al.. (2023). Nine-weeks versus one-year trastuzumab for early-stage HER2+ breast cancer: 10-year update of the Short-HER phase III randomized trial.. Journal of Clinical Oncology. 41(17_suppl). LBA637–LBA637. 2 indexed citations
3.
Lambertini, Matteo, Francesca Poggio, Marco Bruzzone, et al.. (2019). Dose‐dense adjuvant chemotherapy in HER2‐positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. International Journal of Cancer. 147(1). 160–169. 11 indexed citations
4.
Giordano, Guido, Antonio Febbraro, Erica Quaquarini, et al.. (2018). Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports. Oncology. 94(Suppl. 1). 34–44. 1 indexed citations
5.
6.
Conté, Pierfranco, Giancarlo Bisagni, Antonio Frassoldati, et al.. (2017). 9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER.. Journal of Clinical Oncology. 35(15_suppl). 501–501. 22 indexed citations
7.
Cazzaniga, Marina Elena, Giorgio Mustacchi, Emanuela Romagnoli, et al.. (2017). Choice of treatment and adherence to international ESO-ESMO (ABC) guidelines in HR+/HER2-ve metastatic breast cancer (MBC) patients (pts).. Journal of Clinical Oncology. 35(15_suppl). 1057–1057. 1 indexed citations
8.
Cazzaniga, Marina Elena, Giorgio Mustacchi, Monica Giordano, et al.. (2017). Adherence to International ESO-ESMO (ABC) guide-lines in HER2-ve metastatic breast cancer (MBC) patients (pts): Preliminary results of the GIM 13 - AMBRA Study. Annals of Oncology. 28. v83–v84. 1 indexed citations
9.
Mustacchi, Giorgio, Marina Elena Cazzaniga, Emanuela Romagnoli, et al.. (2017). The role of taxanes in HR+ve/HER2-ve metastatic breast cancer (MBC) patients (pts) from adjuvant to metastatic setting in the clinical practice: Results from GIM13-AMBRA study.. Journal of Clinical Oncology. 35(15_suppl). 1055–1055. 1 indexed citations
10.
Bellone, Graziella, Anna Turletti, Elisa Artusio, et al.. (1999). Tumor-Associated Transforming Growth Factor-β and Interleukin-10 Contribute to a Systemic Th2 Immune Phenotype in Pancreatic Carcinoma Patients. American Journal Of Pathology. 155(2). 537–547. 197 indexed citations
11.
Bellone, Graziella, Elisa Artusio, D. Tibaudi, et al.. (1997). Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-β1. Journal of Cellular Physiology. 172(1). 1–11. 62 indexed citations
12.
Bellone, Graziella, Elisa Artusio, Katia Mareschi, et al.. (1997). Bone Marrow Stroma-Derived Prolactin Is Involved in Basal and Platelet-Activating Factor–Stimulated In Vitro Erythropoiesis. Blood. 90(1). 21–27. 42 indexed citations
13.
Bellone, Graziella, Elisa Artusio, Katia Mareschi, et al.. (1997). Bone Marrow Stroma-Derived Prolactin Is Involved in Basal and Platelet-Activating Factor–Stimulated In Vitro Erythropoiesis. Blood. 90(1). 21–27. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihisa Arita Breakdown of academic impact, for papers by Hyun-Joo Lee Breakdown of academic impact, for papers by Yugang Wu Breakdown of academic impact, for papers by Stefania Laurent Breakdown of academic impact, for papers by Anthony Liew Breakdown of academic impact, for papers by JK Larsen Breakdown of academic impact, for papers by Alana M. Neale Breakdown of academic impact, for papers by Holger Hoff Breakdown of academic impact, for papers by Ahmed Bedeir
Rankless by CCL
2026